Original filing text · Part I

Item 3 — Quantitative and Qualitative Disclosures About Market Risk

Goodrx Holdings, Inc. · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

There have been no material changes in our market risk from the disclosure included in Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” of our 2025 10-K.